13 Bladder Cancer Clinical Trials in Dallas, PA (2026)

Q: How do I join a clinical trial in Dallas?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Dallas research site will contact you.

Recruiting Bladder Cancer Studies in Dallas

NCT03193970Recruiting

Measuring Surgical Recovery After Radical Cystectomy

The intent of this study is to establish a registry of post-surgical outcomes in patients undergoing radical cystectomy at MD Anderson Cancer Center and the collaborating institutions. The goals of th...

Dallas, PA2,000 participantsM.D. Anderson Cancer Center

View Study Details

NCT05646485Recruiting

Bladder Cancer Screening Trial

There is currently no accepted screening strategy for patients at high risk of developing bladder cancer. This study will ask patients to complete a urine test every 6 months for 2 years to help asses...

Dallas, PA1,000 participantsUniversity of Texas Southwestern Medical Center

View Study Details

NCT03193541Recruiting

A Novel Multiplex ELISA Assay for Evaluating Patients With Microscopic Hematuria for Bladder Cancer

To improve upon the non-invasive detection of BCa by further validating a multiplex ELISA assay directed at a BCa-associated diagnostic signature in voided urine samples of patients with microscopic h...

Dallas, PA900 participantsCedars-Sinai Medical Center

View Study Details

NCT05825950Recruiting

Artificial Intelligence Prediction Tool in Non-muscle Invasive Bladder Cancer (NMIBC)

This is a multi-center study and the aim is to develop and validate an Artificial Intelligence (AI) -based histologic analysis tool to predict responsiveness to intravesical Bacillus Calmette-Guérin (...

Dallas, PA600 participantsUniversity of Texas Southwestern Medical Center

View Study Details

NCT05080998Recruiting

Longitudinal Bladder Cancer Study for Tumour Recurrence

Surveillance for recurrence of urothelial carcinoma (UC) requires frequent cystoscopy, which is invasive, expensive and time-consuming. An accurate urinary biomarker has the potential to reduce the nu...

Dallas, PA450 participantsPacific Edge Limited

View Study Details

NCT04564781Recruiting

Predicting BCG Response

To date, there are no diagnostics capable of predicting treatment response to intravesical BCG. Because of this severe limitation, nearly 50% of patients treated with BCG fail therapy and will a) requ...

Dallas, PA400 participantsCedars-Sinai Medical Center

View Study Details

NCT03193515Recruiting

A Novel Multiplex ELISA Assay for Surveilling Patients With History of Bladder Cancer

Voided urinary cytology (VUC) is the most widely used urine-based assay for detecting bladder cancer (BCa); however, it fails to detect approximately 50% of low-grade or early stage BCa when it is mos...

Dallas, PA300 participantsCedars-Sinai Medical Center

View Study Details

NCT05796375Recruiting

Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance

The purpose of this research is to determine whether bladder cancer monitoring can be improved by replacing some cystoscopy procedures with urine testing. Specifically, this study examines whether the...

Dallas, PA240 participantsWhite River Junction Veterans Affairs Medical Center

View Study Details

NCT04865939Recruiting

Gemcitabine Versus Water Irrigation in Upper Tract Urothelial Carcinoma

There is a high rate of intravesical (bladder) recurrence following extirpative surgery for upper tract urothelial carcinoma. There is no single established standard of care for prevention of intraves...

Dallas, PA132 participantsUniversity of Texas Southwestern Medical Center

View Study Details

NCT05483868Recruiting

A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer

The main objectives of this study are to determine the feasibility and safety of Belzupacap Sarotalocan (AU-011, bel-sar) treatment of bladder cancer utilizing focal injections with or without laser a...

Dallas, PA55 participantsAura Biosciences

View Study Details

NCT06439836Recruiting

Pembrolizumab Plus CA-4948 for the Treatment of Patients With Progressive Metastatic Urothelial Cancer Despite Prior Immunotherapy

This phase I trial tests the safety, side effects, best dose, and effectiveness of emavusertib (CA-4948) in combination with pembrolizumab in treating patients with urothelial cancer that has spread f...

Dallas, PA27 participantsNational Cancer Institute (NCI)

View Study Details

NCT05239624Recruiting

Enfortumab Vedotin and Pembrolizumab in People with Bladder Cancer

This study will test whether enfortumab vedotin combined with pembrolizumab is an effective treatment for people with bladder cancer (urothelial carcinoma) involving the lymph nodes who are going to h...

Dallas, PA23 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT06394570Recruiting

Enfortumab Vedotin and Stereotactic Radiation for Localized, Cisplatin Ineligible Muscle Invasive Bladder Cancer

STAR-EV will evaluate the combination of enfortumab vedotin plus radiotherapy (RT) as neoadjuvant treatment for muscle invasive bladder cancer prior to radical cystectomy surgery. The study will use "...

Dallas, PA19 participantsUniversity of Texas Southwestern Medical Center

View Study Details

About Bladder Cancer Clinical Trials in Dallas

Bladder cancer occurs in the tissues of the bladder and is one of the most common cancers. It has a high recurrence rate, requiring ongoing monitoring. Treatments include surgery, intravesical therapy, chemotherapy, and immunotherapy.

There are currently 13 bladder cancer clinical trials recruiting participants in Dallas, PA. These studies are seeking a combined 6,146 participants. Research is being sponsored by M.D. Anderson Cancer Center, University of Texas Southwestern Medical Center, Cedars-Sinai Medical Center and 5 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Bladder Cancer Clinical Trials in Dallas — FAQ

Are there bladder cancer clinical trials in Dallas?

Yes, there are 13 bladder cancer clinical trials currently recruiting in Dallas, PA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Dallas?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Dallas research site will contact you about next steps.

Are clinical trials in Dallas free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Dallas studies also compensate for your time and travel.

What bladder cancer treatments are being tested?

The 13 active trials in Dallas are testing new therapies including novel drugs, biologics, and treatment approaches for bladder cancer.

Data updated July 13, 2026 from ClinicalTrials.gov